Northern Trust
ICCC icon

Northern Trust’s ImmuCell ICCC Stock Holding History

Northern Trust’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$148K Sell
14,721
-26,897
-65% -$238K ﹤0.01% 4017
2026
Q1 		$263K Buy
41,618
+3,625
+10% +$23.2K ﹤0.01% 3851
2025
Q4 		$234K Buy
37,993
+199
+0.5% +$1.17K ﹤0.01% 3923
2025
Q3 		$236K Sell
37,794
-4,727
-11% -$29.9K ﹤0.01% 3923
2025
Q2 		$296K Buy
42,521
+137
+0.3% +$799 ﹤0.01% 3811
2025
Q1 		$203K Sell
42,384
-1,990
-4% -$10.2K ﹤0.01% 3939
2024
Q4 		$229K Buy
44,374
+14,982
+51% +$59.7K ﹤0.01% 3946
2024
Q3 		$107K Buy
29,392
+831
+3% +$3.23K ﹤0.01% 4031
2024
Q2 		$139K Sell
28,561
-1,434
-5% -$6.9K ﹤0.01% 3968
2024
Q1 		$159K Sell
29,995
-2,651
-8% -$13.7K ﹤0.01% 3962
2023
Q4 		$166K Buy
32,646
+19,781
+154% +$96.5K ﹤0.01% 3959
2023
Q3 		$68.7K Buy
12,865
+788
+7% +$4K ﹤0.01% 4088
2023
Q2 		$60.4K Sell
12,077
-339
-3% -$1.73K ﹤0.01% 4169
2023
Q1 		$63.4K Sell
12,416
-29
-0.2% -$188 ﹤0.01% 4204
2022
Q4 		$75.9K Sell
12,445
-222
-2% -$1.6K ﹤0.01% 4180
2022
Q3 		$95K Buy
12,667
+34
+0.3% +$278 ﹤0.01% 4128
2022
Q2 		$110K Sell
12,633
-692
-5% -$6K ﹤0.01% 4135
2022
Q1 		$128K Buy
13,325
+50
+0.4% +$431 ﹤0.01% 4276
2021
Q4 		$106K Sell
13,275
-228
-2% -$2.04K ﹤0.01% 4399
2021
Q3 		$127K Buy
13,503
+38
+0.3% +$360 ﹤0.01% 4337
2021
Q2 		$128K Hold
13,465
– – ﹤0.01% 4297
2021
Q1 		$130K Buy
13,465
+600
+5% +$5.63K ﹤0.01% 4230
2020
Q4 		$76K Buy
12,865
+1,271
+11% +$7.4K ﹤0.01% 4171
2020
Q3 		$63K Sell
11,594
-1,819
-14% -$10.1K ﹤0.01% 4068
2020
Q2 		$63K Buy
13,413
+447
+3% +$1.95K ﹤0.01% 4011
2020
Q1 		$49K Buy
+12,966
New +$63.8K ﹤0.01% 3956
2018
Q4 		– Sell
-10,443
Closed -$87K – 4295
2018
Q3 		$87K Hold
10,443
– – ﹤0.01% 4053
2018
Q2 		$71K Buy
+10,443
New +$75K ﹤0.01% 4068

Other funds holding ICCC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
S
Steadtrust Allen, Texas $198M AUM 99.37% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Northern Trust's ICCC Position: Q2 2026 in Review

Northern Trust reduced its ImmuCell (ICCC) stake by 65% in Q2 2026, selling an estimated $238K and leaving 14,721 shares worth $148K. The position accounts for ﹤0.01% of the portfolio, ranked #4017.

Northern Trust first reported a position in ICCC in Q2 2018 and has held it in 28 quarters since. The position peaked at $296K in Q2 2025. 31 funds tracked by Wall St. Rank hold ICCC as of Q2 2026.

  • Northern Trust held 14,721 shares of ImmuCell worth $148K as of Q2 2026.
  • Northern Trust sold 26,897 ImmuCell shares in Q2 2026, an estimated $238K.
  • ImmuCell made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4017 holding.
  • Northern Trust first reported a position in ImmuCell in Q2 2018 and has held it in 28 quarters since.
  • Northern Trust's ImmuCell position peaked at $296K in Q2 2025.
  • 31 funds tracked by Wall St. Rank held ImmuCell as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.